Physician Wealth Advisors’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.17K Hold
917
– – ﹤0.01% 1532
2026
Q2
$1.54K Hold
917
– – ﹤0.01% 1620
2026
Q1
$1.21K Hold
917
– – ﹤0.01% 1569
2025
Q4
$1.72K Hold
917
– – ﹤0.01% 1358
2025
Q3
$1.17K Hold
917
– – ﹤0.01% 1481
2025
Q2
$1.14K Buy
+917
New +$1.06K ﹤0.01% 1315

Other funds holding PACB

Physician Wealth Advisors's PACB Position: Q3 2026 in Review

Physician Wealth Advisors held its Pacific Biosciences (PACB) position steady in Q3 2026 at 917 shares worth $2.17K. The position accounts for ﹤0.01% of the portfolio, ranked #1532.

Physician Wealth Advisors first reported a position in PACB in Q2 2025 and has held it in 6 quarters since. 205 funds tracked by Wall St. Rank hold PACB as of Q3 2026.

  • Physician Wealth Advisors held 917 shares of Pacific Biosciences worth $2.17K as of Q3 2026.
  • Physician Wealth Advisors left its Pacific Biosciences share count unchanged in Q3 2026.
  • Pacific Biosciences made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #1532 holding.
  • Physician Wealth Advisors first reported a position in Pacific Biosciences in Q2 2025 and has held it in 6 quarters since.
  • 205 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.